100 related articles for article (PubMed ID: 11357059)
1. The carboxy-terminal domain of IGF-binding protein-5 inhibits heparin binding to a site in the central domain.
Song H; Shand JH; Beattie J; Flint DJ; Allan GJ
J Mol Endocrinol; 2001 Jun; 26(3):229-39. PubMed ID: 11357059
[TBL] [Abstract][Full Text] [Related]
2. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
[TBL] [Abstract][Full Text] [Related]
3. Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5.
Song H; Beattie J; Campbell IW; Allan GJ
J Mol Endocrinol; 2000 Feb; 24(1):43-51. PubMed ID: 10656996
[TBL] [Abstract][Full Text] [Related]
4. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
Arai T; Clarke J; Parker A; Busby W; Nam T; Clemmons DR
J Biol Chem; 1996 Mar; 271(11):6099-106. PubMed ID: 8626396
[TBL] [Abstract][Full Text] [Related]
5. Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.
Bramani S; Song H; Beattie J; Tonner E; Flint DJ; Allan GJ
J Mol Endocrinol; 1999 Aug; 23(1):117-23. PubMed ID: 10425523
[TBL] [Abstract][Full Text] [Related]
6. Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.
Allan GJ; Tonner E; Szymanowska M; Shand JH; Kelly SM; Phillips K; Clegg RA; Gow IF; Beattie J; Flint DJ
Endocrinology; 2006 Jan; 147(1):338-49. PubMed ID: 16195401
[TBL] [Abstract][Full Text] [Related]
7. Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I.
Shand JH; Beattie J; Song H; Phillips K; Kelly SM; Flint DJ; Allan GJ
J Biol Chem; 2003 May; 278(20):17859-66. PubMed ID: 12626499
[TBL] [Abstract][Full Text] [Related]
8. Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions.
Kalus W; Zweckstetter M; Renner C; Sanchez Y; Georgescu J; Grol M; Demuth D; Schumacher R; Dony C; Lang K; Holak TA
EMBO J; 1998 Nov; 17(22):6558-72. PubMed ID: 9822601
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain.
Twigg SM; Kiefer MC; Zapf J; Baxter RC
J Biol Chem; 1998 Oct; 273(44):28791-8. PubMed ID: 9786878
[TBL] [Abstract][Full Text] [Related]
10. A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit.
Twigg SM; Kiefer MC; Zapf J; Baxter RC
Endocrinology; 2000 Jan; 141(1):454-7. PubMed ID: 10614670
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor (IGF)-binding protein-4 proteolytic degradation in bovine, equine, and porcine preovulatory follicles: regulation by IGFs and heparin-binding domain-containing peptides.
Mazerbourg S; Zapf J; Bar RS; Brigstock DR; Monget P
Biol Reprod; 2000 Aug; 63(2):390-400. PubMed ID: 10906042
[TBL] [Abstract][Full Text] [Related]
12. Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis.
Beattie J; Phillips K; Shand JH; Szymanowska M; Flint DJ; Allan GJ
J Mol Endocrinol; 2005 Feb; 34(1):163-75. PubMed ID: 15691886
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth.
Nam TJ; Busby WH; Rees C; Clemmons DR
Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186
[TBL] [Abstract][Full Text] [Related]
14. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes.
Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA
Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding.
Campbell PG; Andress DL
Am J Physiol; 1997 Nov; 273(5):E1005-13. PubMed ID: 9374688
[TBL] [Abstract][Full Text] [Related]
16. Expression and characterization of a serine protease that preferentially cleaves insulin-like growth factor binding protein-5.
Hou J; Clemmons DR; Smeekens S
J Cell Biochem; 2005 Feb; 94(3):470-84. PubMed ID: 15534875
[TBL] [Abstract][Full Text] [Related]
17. The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5.
Zesławski W; Beisel HG; Kamionka M; Kalus W; Engh RA; Huber R; Lang K; Holak TA
EMBO J; 2001 Jul; 20(14):3638-44. PubMed ID: 11447105
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3.
Réhault S; Monget P; Mazerbourg S; Tremblay R; Gutman N; Gauthier F; Moreau T
Eur J Biochem; 2001 May; 268(10):2960-8. PubMed ID: 11358513
[TBL] [Abstract][Full Text] [Related]
19. IGFBP-3 and IGFBP-5 associate with the cell binding domain (CBD) of fibronectin.
Beattie J; Kreiner M; Allan GJ; Flint DJ; Domingues D; van der Walle CF
Biochem Biophys Res Commun; 2009 Apr; 381(4):572-6. PubMed ID: 19236847
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional and post-translational regulation of insulin-like growth factor-binding protein-5 in rat articular chondrocytes.
Matsumoto T; Gargosky SE; Oh Y; Rosenfeld RG
J Endocrinol; 1996 Feb; 148(2):355-69. PubMed ID: 8699150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
